ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2018. The put-call ratio across all filers is 24.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $105,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
| Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
| Founders Capital Management | 18,000 | $20,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |